HomeRX • CVE
add
Biosyent Inc
Previous close
$12.18
Day range
$12.20 - $12.25
Year range
$9.20 - $12.49
Market cap
140.57M CAD
Avg Volume
3.95K
P/E ratio
16.38
Dividend yield
1.63%
Primary exchange
CVE
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 12.22M | 27.90% |
Operating expense | 5.84M | 22.78% |
Net income | 2.68M | 16.22% |
Net profit margin | 21.95 | -9.11% |
Earnings per share | — | — |
EBITDA | 3.65M | 28.12% |
Effective tax rate | 26.50% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.40M | 37.10% |
Total assets | 47.79M | 5.09% |
Total liabilities | 7.88M | -2.98% |
Total equity | 39.90M | — |
Shares outstanding | 11.26M | — |
Price to book | 3.44 | — |
Return on assets | 18.79% | — |
Return on capital | 21.62% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.68M | 16.22% |
Cash from operations | 2.77M | -58.05% |
Cash from investing | 450.87K | 108.95% |
Cash from financing | -607.04K | -9.43% |
Net change in cash | 2.62M | 166.73% |
Free cash flow | 2.00M | 16.54% |
About
Founded
1947
Headquarters
Website
